T-DM1-related telangiectasias: a potential role in secondary bleeding events.

Subjects

Subjects :

Ado-Trastuzumab Emtansine
Clinical Trials, Phase III as Topic
Female
Humans
Maytansine adverse effects
Trastuzumab
Antibodies, Monoclonal, Humanized adverse effects
Antineoplastic Agents adverse effects
Breast Neoplasms drug therapy
Hemorrhage chemically induced
Maytansine analogs & derivatives
Telangiectasis chemically induced

Details

Language :

English

ISSN :

1569-8041

Volume :

26

Issue :

2

Database :

MEDLINE

Journal :

Annals of oncology : official journal of the European Society for Medical Oncology

Publication Type :

Editorial & Opinion

Accession number :

25403586

Full Text :

https://doi.org/10.1093/annonc/mdu533